Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00057317

Public ClinicalTrials.gov record NCT00057317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 11:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, Placebo-controlled Dose-ranging Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to determine the dose(s) of Ro 205-2349 which, when compared to placebo, are efficacious, safe and tolerable in improving glycemic control in patients with type 2 diabetes. Doses of 5 to 20 mg/day will be studied.

Study identification

NCT ID
NCT00057317
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2001 (Type not available)
Primary completion
Dec 2003 (Actual)
Completion
Dec 2003 (Actual)
Last update posted
Aug 24, 2016

2001 – 2003

United States locations

U.S. sites
65
U.S. states
28
U.S. cities
60
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Mesa Arizona 85206 —
Not listed Scottsdale Arizona 85251 —
Not listed Tucson Arizona 85710 —
Not listed Tucson Arizona 85723 —
Not listed Encino California 91436 —
Not listed Fountain Valley California 92708 —
Not listed Fremont California 94538 —
Not listed Fresno California 93720 —
Not listed Irvine California 92618 —
Not listed Modesto California 95355 —
Not listed Pasadena California 91106 —
Not listed San Bruno California 94066 —
Not listed Santa Rosa California 95405 —
Not listed Sunnyvale California 94086 —
Not listed Hamden Connecticut 06518 —
Not listed Norwalk Connecticut 06850 —
Not listed Newark Delaware 19713 —
Not listed Hollywood Florida 33021 —
Not listed Jacksonville Florida 32204 —
Not listed Ocala Florida 34471 —
Not listed West Palm Beach Florida 33401 —
Not listed Atlanta Georgia 30322 —
Not listed Lawrenceville Georgia 30045 —
Not listed Honolulu Hawaii 96813 —
Not listed Indianapolis Indiana 46214-2985 —
Not listed Overland Park Kansas 66211 —
Not listed New Orleans Louisiana 70121 —
Not listed Boston Massachusetts 02215 —
Not listed Kansas City Missouri 64111 —
Not listed St Louis Missouri 63104 —
Not listed St Louis Missouri 63110 —
Not listed Billings Montana 59101 —
Not listed Omaha Nebraska 68198-3032 —
Not listed Las Vegas Nevada 89102 —
Not listed Trenton New Jersey 08611 —
Not listed Albuquerque New Mexico 87106 —
Not listed Buffalo New York 14209 —
Not listed New Hyde Park New York 11040 —
Not listed Rochester New York 14609 —
Not listed Charlotte North Carolina 28209 —
Not listed Durham North Carolina 27710 —
Not listed Greenville North Carolina 27858-4354 —
Not listed Morrisville North Carolina 27560 —
Not listed Portland Oregon 97201 —
Not listed Tualatin Oregon 97062 —
Not listed Camp Hill Pennsylvania 17011 —
Not listed Connellsville Pennsylvania 15425 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Philadelphia Pennsylvania 19107 —
Not listed East Providence Rhode Island 02914 —
Not listed Greer South Carolina 29651 —
Not listed Memphis Tennessee 38119 —
Not listed Dallas Texas 75230 —
Not listed El Paso Texas 79902 —
Not listed Houston Texas 77030 —
Not listed Midland Texas 79705 —
Not listed San Antonio Texas 78229-4801 —
Not listed San Antonio Texas 78229 —
Not listed San Antonio Texas 78284 —
Not listed Lebanon Virginia 24266 —
Not listed Richmond Virginia 23294 —
Not listed Virginia Beach Virginia 23451 —
Not listed Edmonds Washington 98026 —
Not listed Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00057317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2016 · Synced Nov 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00057317 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →